Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products

Holya A Lafta1, Ali H AbdulHussein2, Saif A J Al-Shalah3

  • 1Department of Medical Laboratories, Al-Nisour University College, Baghdad, Iraq.

Insights

Tumor-associated macrophages (TAMs) promote tumor growth and drug resistance. Natural compounds like melatonin and curcumin can modulate TAMs, potentially enhancing anti-tumor immunity.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Tumor-associated macrophages (TAMs) are key regulators of the tumor microenvironment (TME), promoting tumor progression, immune suppression, and resistance to anticancer therapies.
  • TAMs interact with various cells within the TME, including cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, impairing anti-tumor immune responses.
  • Through growth factors like TGF-β and cross-talk with regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), cancer-associated fibroblasts (CAFs), and cancer cells, TAMs drive proliferation, invasion, angiogenesis, and metastasis.

Approach:

  • This review synthesizes current knowledge on the modulatory effects of naturally derived agents on TAMs.
  • Focuses on agents such as melatonin, curcumin, resveratrol, and apigenin, highlighting their potential to reprogram TAMs within the TME.
  • Explores how these natural compounds can counteract TAM-mediated immunosuppression and promote anti-tumor immunity.

Key Points:

  • TAMs contribute significantly to tumor progression, immune evasion, and therapeutic resistance.
  • Natural compounds, including flavonoids, melatonin, and curcumin, demonstrate potential in modulating TAM functions.
  • Targeting TAMs with these natural agents offers a promising strategy to overcome tumor resistance and enhance the efficacy of cancer treatments.

Conclusions:

  • Modulating TAMs with natural agents represents a viable strategy to inhibit tumor growth, invasion, and metastasis.
  • These natural compounds may enhance anti-tumor immunity by reprogramming the immunosuppressive TME orchestrated by TAMs.
  • Further research into these naturally derived agents could lead to novel therapeutic adjuvants for cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K